Inventor · disambiguated record

Tom M. Lam

Also filed as: LAM TOM M

7 granted patents·3 pending applications·11 citations·filing 2018–2024

77Inventor score

Technology areasC07D A61P

Files withTHERAVANCE BIOPHARMA R&D IP LLC8 MERCK SHARP & DOHME LLC2

Top patents by PatentIndex Score

10 records

0187US10538513B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Jan 21, 2020·4 cites·16 claims
0285US10392368B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 27, 2019·5 cites·46 claims
0383US10968205B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Apr 6, 2021·1 cites·26 claims
0480US10851102B2Imidazole and triazole containing bicyclic compounds as JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Dec 1, 2020·1 cites·19 claims
0570US2022119369A1Pyrazolo and triazolo bicyclic compounds as jak kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Application pending·0 cites
0660US11339160B2Imidazole and triazole containing bicyclic compounds as JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted May 24, 2022·0 cites·17 claims
0758US2025223290A1Azaindazole derivatives useful as inhibitors of nod-like receptor protein 3MERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
0858US2025195511A1Indazole derivatives useful as inhibitors of nod-like receptor protein 3MERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
0955US12384761B2Imidazolo indazole compounds as JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Aug 12, 2025·0 cites·21 claims
1049US11697648B2Fused pyrimidine pyridinone compounds as JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Jul 11, 2023·0 cites·22 claims

Join the waitlist — get patent alerts

Get an alert when Tom M. Lam files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →